Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance

Abstract Background Cardiovascular magnetic resonance (CMR) is part of the diagnostic work-up for cardiac amyloidosis (CA). Deep learning (DL) is an application of artificial intelligence that may allow to automatically analyze CMR findings and establish the likelihood of CA. Methods 1.5 T CMR was p...

Full description

Bibliographic Details
Main Authors: Nicola Martini, Alberto Aimo, Andrea Barison, Daniele Della Latta, Giuseppe Vergaro, Giovanni Donato Aquaro, Andrea Ripoli, Michele Emdin, Dante Chiappino
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Journal of Cardiovascular Magnetic Resonance
Subjects:
Online Access:https://doi.org/10.1186/s12968-020-00690-4
id doaj-66b4abdccc024c8b8359d61499fba750
record_format Article
spelling doaj-66b4abdccc024c8b8359d61499fba7502020-12-08T13:44:07ZengBMCJournal of Cardiovascular Magnetic Resonance1532-429X2020-12-0122111110.1186/s12968-020-00690-4Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonanceNicola Martini0Alberto Aimo1Andrea Barison2Daniele Della Latta3Giuseppe Vergaro4Giovanni Donato Aquaro5Andrea Ripoli6Michele Emdin7Dante Chiappino8Deep Health Unit, Fondazione Toscana Gabriele MonasterioInstitute of Life Sciences, Scuola Superiore Sant’AnnaInstitute of Life Sciences, Scuola Superiore Sant’AnnaDeep Health Unit, Fondazione Toscana Gabriele MonasterioInstitute of Life Sciences, Scuola Superiore Sant’AnnaCardiology Division, Fondazione Toscana Gabriele MonasterioDeep Health Unit, Fondazione Toscana Gabriele MonasterioInstitute of Life Sciences, Scuola Superiore Sant’AnnaDeep Health Unit, Fondazione Toscana Gabriele MonasterioAbstract Background Cardiovascular magnetic resonance (CMR) is part of the diagnostic work-up for cardiac amyloidosis (CA). Deep learning (DL) is an application of artificial intelligence that may allow to automatically analyze CMR findings and establish the likelihood of CA. Methods 1.5 T CMR was performed in 206 subjects with suspected CA (n = 100, 49% with unexplained left ventricular (LV) hypertrophy; n = 106, 51% with blood dyscrasia and suspected light-chain amyloidosis). Patients were randomly assigned to the training (n = 134, 65%), validation (n = 30, 15%), and testing subgroups (n = 42, 20%). Short axis, 2-chamber, 4-chamber late gadolinium enhancement (LGE) images were evaluated by 3 networks (DL algorithms). The tags “amyloidosis present” or “absent” were attributed when the average probability of CA from the 3 networks was ≥ 50% or < 50%, respectively. The DL strategy was compared to a machine learning (ML) algorithm considering all manually extracted features (LV volumes, mass and function, LGE pattern, early blood-pool darkening, pericardial and pleural effusion, etc.), to reproduce exam reading by an experienced operator. Results The DL strategy displayed good diagnostic accuracy (88%), with an area under the curve (AUC) of 0.982. The precision (positive predictive value), recall score (sensitivity), and F1 score (a measure of test accuracy) were 83%, 95%, and 89% respectively. A ML algorithm considering all CMR features had a similar diagnostic yield to DL strategy (AUC 0.952 vs. 0.982; p = 0.39). Conclusions A DL approach evaluating LGE acquisitions displayed a similar diagnostic performance for CA to a ML-based approach, which simulates CMR reading by experienced operators.https://doi.org/10.1186/s12968-020-00690-4Deep learningArtificial intelligenceDiagnosisAmyloidosisCardiovascular magnetic resonance
collection DOAJ
language English
format Article
sources DOAJ
author Nicola Martini
Alberto Aimo
Andrea Barison
Daniele Della Latta
Giuseppe Vergaro
Giovanni Donato Aquaro
Andrea Ripoli
Michele Emdin
Dante Chiappino
spellingShingle Nicola Martini
Alberto Aimo
Andrea Barison
Daniele Della Latta
Giuseppe Vergaro
Giovanni Donato Aquaro
Andrea Ripoli
Michele Emdin
Dante Chiappino
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance
Journal of Cardiovascular Magnetic Resonance
Deep learning
Artificial intelligence
Diagnosis
Amyloidosis
Cardiovascular magnetic resonance
author_facet Nicola Martini
Alberto Aimo
Andrea Barison
Daniele Della Latta
Giuseppe Vergaro
Giovanni Donato Aquaro
Andrea Ripoli
Michele Emdin
Dante Chiappino
author_sort Nicola Martini
title Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance
title_short Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance
title_full Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance
title_fullStr Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance
title_full_unstemmed Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance
title_sort deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance
publisher BMC
series Journal of Cardiovascular Magnetic Resonance
issn 1532-429X
publishDate 2020-12-01
description Abstract Background Cardiovascular magnetic resonance (CMR) is part of the diagnostic work-up for cardiac amyloidosis (CA). Deep learning (DL) is an application of artificial intelligence that may allow to automatically analyze CMR findings and establish the likelihood of CA. Methods 1.5 T CMR was performed in 206 subjects with suspected CA (n = 100, 49% with unexplained left ventricular (LV) hypertrophy; n = 106, 51% with blood dyscrasia and suspected light-chain amyloidosis). Patients were randomly assigned to the training (n = 134, 65%), validation (n = 30, 15%), and testing subgroups (n = 42, 20%). Short axis, 2-chamber, 4-chamber late gadolinium enhancement (LGE) images were evaluated by 3 networks (DL algorithms). The tags “amyloidosis present” or “absent” were attributed when the average probability of CA from the 3 networks was ≥ 50% or < 50%, respectively. The DL strategy was compared to a machine learning (ML) algorithm considering all manually extracted features (LV volumes, mass and function, LGE pattern, early blood-pool darkening, pericardial and pleural effusion, etc.), to reproduce exam reading by an experienced operator. Results The DL strategy displayed good diagnostic accuracy (88%), with an area under the curve (AUC) of 0.982. The precision (positive predictive value), recall score (sensitivity), and F1 score (a measure of test accuracy) were 83%, 95%, and 89% respectively. A ML algorithm considering all CMR features had a similar diagnostic yield to DL strategy (AUC 0.952 vs. 0.982; p = 0.39). Conclusions A DL approach evaluating LGE acquisitions displayed a similar diagnostic performance for CA to a ML-based approach, which simulates CMR reading by experienced operators.
topic Deep learning
Artificial intelligence
Diagnosis
Amyloidosis
Cardiovascular magnetic resonance
url https://doi.org/10.1186/s12968-020-00690-4
work_keys_str_mv AT nicolamartini deeplearningtodiagnosecardiacamyloidosisfromcardiovascularmagneticresonance
AT albertoaimo deeplearningtodiagnosecardiacamyloidosisfromcardiovascularmagneticresonance
AT andreabarison deeplearningtodiagnosecardiacamyloidosisfromcardiovascularmagneticresonance
AT danieledellalatta deeplearningtodiagnosecardiacamyloidosisfromcardiovascularmagneticresonance
AT giuseppevergaro deeplearningtodiagnosecardiacamyloidosisfromcardiovascularmagneticresonance
AT giovannidonatoaquaro deeplearningtodiagnosecardiacamyloidosisfromcardiovascularmagneticresonance
AT andrearipoli deeplearningtodiagnosecardiacamyloidosisfromcardiovascularmagneticresonance
AT micheleemdin deeplearningtodiagnosecardiacamyloidosisfromcardiovascularmagneticresonance
AT dantechiappino deeplearningtodiagnosecardiacamyloidosisfromcardiovascularmagneticresonance
_version_ 1724389276160884736